Lilly Blocked From Selling Boehringer's Tradjenta Until At Least May 31
This article was originally published in The Pink Sheet Daily
Executive Summary
Judge says Lilly would be sharing confidential Amylin data by having its Byetta sales reps promote Tradjenta; Lilly plans to increase its diabetes sales force from 774 to 1,144.